Global Computer Aided-Drug Discovery Market Size, Trends & Opportunity, By Type (Structure Based Drug Design, Ligand-based Drug Design, Sequence-based Approaches), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Others), By End User (Pharmaceutical Companies, Biotechnology Companies, Research Laboratories), By Region & forecast till 2027.
Global Computer Aided-Drug Discovery Market
The Global Computer Aided-Drug Discovery Market is projected to grow from $2.9 billion in 2021 to $4.5 billion by 2027 at a CAGR of over 9.45% during the forecast period that is from 2022-2027.
Computer Aided-Drug Discovery (CADD) is a latest technique in that researchers & analysts use a combination of software to analyse, design, develop, monitor, and study a three-dimensional structure of targeted disease molecule and its complement biomolecule ligand. Computer Aided-Drug Discovery (CADD) is a leading-edge computational method for recognizing & implementing potential leads in drug discovery. CADD is being also used to enhance the quality of leads that have been recognized.
Market Drivers
Rising incidence of Long-term & unknown diseases are anticipated to accelerate demand for fast drug development, driving the Computer Aided-Drug Discovery market growth in the upcoming time period. Strategic affiliation between market players integrate with increasing drug demand are expected to boost the global market. As reported by Premier, inc., a famous healthcare enhancement company the need of novel drug for treatment of CVD conditions has boosted as a result of COVID-19 crises. The facts and figures presented by Premier, inc., show that the demand for the development of new drug molecules is anticipated to growing, which may have a positive impact on the global computer-aided drug discovery market during the analysis period.
Market Restrains
A shortage of skillful labour to operate Computer Aided-Drug Discovery solution may impede global market growth. Lower product penetration in appearing economies is as well hampering drug discovery industry. As computer-aided drug discovery is a modern upgraded technology lots of professionals may either not aware about it or they don’t know how make use of technology to discover drug. Additionally, it is very complicated process which requires skills for operation. People require plenty time to master the use of software. These factors are anticipated to restrain the market growth in future.
Market Segmentation
The Global Computer Aided-Drug Discovery Market is segmented into Type, Therapeutic Area, End user. By Type such as Structure Based Drug Design, Ligand-based Drug Design, Sequence-based Approaches. By Therapeutic Area such as Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Others. By End user such as Pharmaceutical Companies, Biotechnology Companies, Research Laboratories.
Regional Analysis
The Global Computer Aided-Drug Discovery Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America computer-aided drug discovery market is expected to bring out maximum revenue during the forecast time period. The Asia-Pacific is projected to grow with the highest CAGR of 12.84% in the forecast period.
Key Players
Various Key Players are listed in this report such as Aris Pharmaceuticals, Inc, Charles River Laboratories, Aragon Life Sciences Pvt. Ltd., Bayer AG, Schrödinger, Inc., AstraZeneca, Bioduro-Sundia,Albany Molecular Research Inc. (AMRI), BOCSCI Inc.
Market Taxonomy
By Type
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook